This phase II trial studies how well olaparib with cediranib or AZD6738 works in treating patients with germline BRCA mutated breast cancer that has spread to …

Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04090567

Observational

TUBectomy With Delayed Oophorectomy as Alternative for Risk-reducing Salpingo-oophorectomy in High Risk Women to Assess the Safety of Prevention: TUBA-WISP II Study.

The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in hi…

BRCA1 Gene MutationBRCA2 Gene MutationRAD51C Gene Mutation+3 more

~Estimated

~$10 – $6,250

University Medical Center NijmegenNCT04294927